Gainesville Environmental Fi

North Florida Land Trust Inc is a non-profit organization dedicated to the preservation and protection of North Florida's natural landscapes, safeguarding irreplaceable habitats and biodiversity across the region. With a significant impact that includes the preservation of 44,000 acres and the protection of 25 threatened and endangered species, NFLT actively works to conserve vital natural resources through community engagement and partnerships. Through initiatives like the Corridor to Coast program and local projects such as the Bogey Creek Preserve, NFLT aims to enhance public access to green spaces while promoting the ecological health of the area. Their ongoing efforts highlight the commitment to maintaining North Florida's unique environmental integrity for future generations. Generated from the website

The Foundation for Applied Molecular Evolution (FfAME) is a pioneering research institution based in Alachua, Florida, dedicated to exploring the intersection of biology, chemistry, and other scientific disciplines to address fundamental questions about life and its origins. With a focus on innovative research in areas such as DNA technology, synthetic biology, and personalized medicine, FfAME aims to enhance our understanding of biological systems from the cellular level to the larger ecosystem. Founded by leading scientists, FfAME contributes significantly to advancements in medical genomics and systems biology. Through its outreach efforts and collaborations, the foundation engages with the scientific community and the public, fostering dialogue about the implications of its research on life's existence and the potential for extraterrestrial life. Generated from the website

Discovery Cure Institute, Inc. (DCI) is a certified 501(c)(3) Florida Non-Profit Corporation established in 2018, dedicated to the discovery of novel cures for cancer, infectious diseases, and CNS disorders. DCI leverages high-throughput and in silico screening techniques, supported by a library of 800,000 compounds acquired from the Sanford Burnham Prebys Medical Discovery Institute. With advanced capabilities in assay development, ultra high-throughput screening, and computational chemistry, DCI collaborates with Alchem Laboratories Corporation to rapidly identify active compounds that influence biomolecular pathways. The integrated technologies at the Alchem-DCI screening facility optimize the drug discovery process, moving from initial hit identification to lead generation and optimization. Generated from the website